<DOC>
	<DOC>NCT02358525</DOC>
	<brief_summary>The aim of this descriptive study is to examine potential changes regarding inflammatory cytokine levels, depressive symptoms and quality of life over the course of the 4-week inpatient rehabilitation program which includes a cassette of modalities including counseling, psychosocial education and supervised exercise training as a main pillar, and to further investigate if there are correlations between changes in immune regulation, depressive symptoms and quality of life.</brief_summary>
	<brief_title>Effects of a Rehabilitation Program on Immune Activation and Mood in Heart Failure Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Depression</mesh_term>
	<criteria>Diagnosis of heart failure with reduced ejection fraction (HFREF) with an EF â‰¤ 45%, NYHA (New York Heart Association) I III; ACC/AHA (American College of Cariology/ American Heart Association) stage C, irrespective of etiology Clinically stable patients without deterioration or hospitalization due to heart failure within the last 4 weeks Neurohormonal medication according to the ESC (European Society of Cardiology) guidelines for the treatment of chronic heart failure consisting of antagonists of the ReninAngiotensinAldosterone System (RAAS) and betablockers as indicated. Ability to fully understand all elements of and sign the written informed consent before initiation of the study Fluid retention of cardiac decompensation, necessitating i.v. diuretic therapy Myocardial infarction within the last 2 months Surgery including cardiovascular or valvular surgery within 3 Months Uncontrolled proinflammatory comorbidities (e.g. Diabetes mellitus HbA1c &gt;9%, COPD ( chronic obstructive pulmonary disease) &gt;II, active rheumatic diseases and autoimmune disorders) Current infectious diseases ( e.g. pneumonia, COPD exacerbations or urinary tract infections) Morbid obesity: BMI &gt; 40 Alcohol or drug abuse psychiatric disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>